Global incidence of prostate cancer in developing and developed countries with changing age structures

PLoS One. 2019 Oct 24;14(10):e0221775. doi: 10.1371/journal.pone.0221775. eCollection 2019.

Abstract

To investigate the global incidence of prostate cancer with special attention to the changing age structures. Data regarding the cancer incidence and population statistics were retrieved from the International Agency for Research on Cancer in World Health Organization. Eight developing and developed jurisdictions in Asia and the Western countries were selected for global comparison. Time series were constructed based on the cancer incidence rates from 1988 to 2007. The incidence rate of the population aged ≥ 65 was adjusted by the increasing proportion of elderly population, and was defined as the "aging-adjusted incidence rate". Cancer incidence and population were then projected to 2030. The aging-adjusted incidence rates of prostate cancer in Asia (Hong Kong, Japan and China) and the developing Western countries (Costa Rica and Croatia) had increased progressively with time. In the developed Western countries (the United States, the United Kingdom and Sweden), we observed initial increases in the aging-adjusted incidence rates of prostate cancer, which then gradually plateaued and even decreased with time. Projections showed that the aging-adjusted incidence rates of prostate cancer in Asia and the developing Western countries were expected to increase in much larger extents than the developed Western countries.

MeSH terms

  • Adult
  • Age Distribution
  • Age Factors
  • Aged
  • China / epidemiology
  • Costa Rica / epidemiology
  • Databases, Factual / statistics & numerical data*
  • Developed Countries / classification
  • Developed Countries / statistics & numerical data*
  • Developing Countries / classification
  • Developing Countries / statistics & numerical data*
  • Hong Kong / epidemiology
  • Humans
  • Incidence
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / epidemiology*
  • Sweden / epidemiology
  • United Kingdom / epidemiology
  • United States / epidemiology
  • World Health Organization

Grants and funding

The author(s) received no specific funding for this work.